Camzyos 5 MG
Ended Awarded Last action
- Contract number
- 36C24526N0380
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $6,164
Award facts
- Contract value 100% obligated
- $6,163.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company received a $6,163.72 firm fixed-price delivery order from Veterans Integrated Service Network 5 (VISN 5) for CAMZYOS 5 MG, a specialty oncology pharmaceutical. The award was issued on March 5, 2026, with an ultimate completion date of March 10, 2026, and performance will be conducted at the place of performance in Memphis, Tennessee. This delivery order is a call against Bristol-Myers Squibb's Federal Supply Schedule (FSS) contract (ID: 36F79724D0101) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule with the Department of Veterans Affairs, which carries a substantial ceiling value of approximately $12.3 billion and extends through April 30, 2029. The FSS contract was awarded on May 1, 2024, and contains no set-aside designations.
This delivery order supports the Veterans Health Administration's mission to provide advanced oncology and specialized pharmaceutical treatments to eligible veterans across the VA healthcare system. Bristol-Myers Squibb, a global biopharmaceutical manufacturer headquartered in Lawrenceville, New Jersey, has been actively engaged as a federal contractor since 2006 and specializes in innovative cancer treatments and cell therapies. The company has received more than fifty documented delivery orders through the FSS vehicle since 2022, reflecting sustained demand for its specialized oncology products within the VA network. CAMZYOS is one of several specialty oncology pharmaceuticals supplied by Bristol-Myers Squibb to support the VA's therapeutic needs across multiple Veterans Integrated Service Networks.
Quick answers
Who was awarded contract 36C24526N0380?
36C24526N0380 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 5, 2026.
How much is contract 36C24526N0380 worth?
The government has obligated $6,164 on 36C24526N0380.
Is contract 36C24526N0380 an order under another contract?
Yes. 36C24526N0380 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0380 competed?
The extent of competition for 36C24526N0380 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award